Navigation Links
Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Assessment of Its Phase I/II Trial of tgAAC94 for Inflammatory Arthritis
Date:12/3/2007

SEATTLE, Dec. 3 /PRNewswire-FirstCall/ -- Targeted Genetics Corporation (Nasdaq: TGEN) today reported on the National Institutes of Health (NIH) Recombinant DNA Advisory Committee's (RAC) assessment of the previously reported fatal serious adverse event (SAE) in the Phase I/II trial of tgAAC94 for inflammatory arthritis.

The Committee's opinion is that the subject's death was a result of complications from an opportunistic infection, disseminated histoplasmosis, which caused the study participant to experience a retroperitoneal hematoma and multi-organ failure. Further, the RAC observed that an apparent risk factor that may have had an impact on the patient's susceptibility to the infection was the patient's longstanding systemic treatment for rheumatoid arthritis with a TNF antagonist, adalimumab. The RAC indicated there was insufficient data available to determine if the patient may have had an immune response to the local injection of tgAAC94 as a part of the clinical trial in which she was participating. The panel also observed, however, that if there was an immune response to the intra-articular injection of tgAAV94 in this patient, it was very unlikely to have been a significant contributor, if at all, to the subject's clinical course and was not the cause of her death.

On October 23, 2007, upon comprehensive review of all available data, which were also presented at the American College of Rheumatology Annual Meeting on November 10, the study's independent data safety monitoring board concluded that the SAE was not related to the tgAAC94 product. In addition, as recently reported, the U.S. Food and Drug Administration (FDA) also released the trial from clinical hold, permitting the clinical trial
'/>"/>

SOURCE Targeted Genetics Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Study suggests brain tumors need treatment with multiple targeted drugs
2. Data Show SuperGens Multi-Targeted Tyrosine Kinase Inhibitor Demonstrates Pre-clinical Activity in Glioblastoma Multiforme
3. Research suggests targeted treatment strategies for lupus
4. S*BIO Expands Pipeline With the Development of a Unique Flt3 -CDK Inhibitor as a Targeted Therapy for Acute Leukemias
5. Genetics Hold Promise, Challenges for Cancer Care
6. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
7. Salugen to Present Research on Generational Associations of Reward Deficiency Syndrome at XVth World Congress on Psychiatric Genetics
8. Obesity genetics
9. The genetics of MLL leukemogenesis
10. Vanda Pharmaceuticals to Present New Data on Iloperidone at the 2007 American Society of Human Genetics Annual Meeting
11. Clarient Names Michele Hibbard, Ph.D. Director of Genetics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Washington, D.C. (PRWEB) October 22, 2014 With ... November, a national survey by the American Institutes for Research ... they know how to use health insurance, but 42 percent ... review a plan’s details before signing up for coverage. , ... literacy, with only 20 percent able to calculate correctly how ...
(Date:10/22/2014)... 22, 2014 Losing Weight Your Body’s Way ... staring you in the face, it certainly can be difficult ... your body an extra favor by doing it the healthy ... diets. Instead, listen to your body, exercise regularly, and choose ... essential to losing weight; you need to exercise more and ...
(Date:10/22/2014)... WALTHAM, MA (PRWEB) October 22, 2014 ... developing new solutions for the treatment of bacterial infections, ... J. Sinskey has joined its board of directors. ... Microbiology and Engineering Systems at The Massachusetts Institute of ... the MIT faculty since 1968. Dr. Sinskey also holds ...
(Date:10/22/2014)... Tara Haelle HealthDay Reporter ... drinking among young adult men may lead to increased blood ... didn,t cause a similar rise in blood pressure for young ... fact, when young adult women drank lightly or moderately, their ... study found. "This finding parallels studies in older adult ...
(Date:10/22/2014)... HealthDay Reporter TUESDAY, Oct. 21, 2014 (HealthDay News) -- ... NBC News in Liberia has cleared the virus from ... Medical Center in Omaha, where he had been treated for the ... confirmed by the U.S. Centers for Disease Control and Prevention found ... NBC News reported Tuesday night. "Recovering from Ebola is ...
Breaking Medicine News(10 mins):Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 2Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 3Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 4Health News:ReductionGuruMD Presents Ways to Improve Your Weight Loss Results 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 4Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 2Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 3
... low oxygen, study suggests, , TUESDAY, Feb. 2 (HealthDay News) ... crucial to sudden infant death syndrome (SIDS), new research finds. ... of serotonin -- an important regulator of involuntary functions such ... died of other causes, the study found. This finding may ...
... Feb. 2 The National Committee for Quality Assurance (NCQA) ... of Ohio , the first health plan in Ohio ... , Medical Mutual,s wellness program is one of only 15 in ... , WHP is a comprehensive assessment of key areas of health ...
... over possible link between MMR vaccine, developmental disorder ... British medical journal The Lancet on Tuesday ... the measles, mumps and rubella vaccine to autism and ... Feb. 28, 1998, set off a worldwide furor, with ...
... (fictitious name) was born in Bangladesh yet raised in Montreal. At ... pretext of visiting her sick grandmother. The young woman was then ... resistance. The girl later wrote to her mother that she ... raped. After two months, her mother granted her return to Montreal. ...
... ... ... 22, 2010 -- Professional athletes, everyday athletes and even the occasional weekend warriors ... isn’t new technology – it’s been widely used and popular among European athletes ...
... parents over possible link between MMR vaccine, developmental disorder ... prestigious British medical journal The Lancet on ... linked the measles, mumps and rubella vaccine to autism ... Feb. 28, 1998, set off a worldwide furor, ...
Cached Medicine News:Health News:Serotonin May Be Key to Sudden Infant Deaths 2Health News:Serotonin May Be Key to Sudden Infant Deaths 3Health News:Medical Mutual is the First Ohio Health Plan to Receive NCQA Wellness & Health Accreditation 2Health News:Controversial Autism Study Retracted by Medical Journal 2Health News:Controversial Autism Study Retracted by Medical Journal 3Health News:Controversial Autism Study Retracted by Medical Journal 4Health News:From Quebec to France: forced marriages still exist 2Health News:Electrical Muscle Stimulation Proven to Enhance Muscle Development and Sports Performance 2Health News:Electrical Muscle Stimulation Proven to Enhance Muscle Development and Sports Performance 3Health News:Electrical Muscle Stimulation Proven to Enhance Muscle Development and Sports Performance 4Health News:Flawed Autism Study Retracted by Medical Journal 2Health News:Flawed Autism Study Retracted by Medical Journal 3
(Date:10/22/2014)... , Oct. 22, 2014  Quest Diagnostics (NYSE: ... information services, today announced that its Board of Directors ... a director, effective December 1, 2014. Including Dr. Leiden, ... is the Chairman, President and CEO of Vertex Pharmaceuticals. ... scientific and commercial experience in the pharmaceutical and biotechnology ...
(Date:10/22/2014)... , Oct. 22, 2014 Moms are ... health trackers for themselves and their kids, according to ... Report: Health & Fitness Go Mobile for Moms, the ... Series. BabyCenter, the number 1 pregnancy and parenting web ... that 55 percent of moms surveyed say they can,t ...
(Date:10/22/2014)... , Oct. 22, 2014  With a vision ... health medications, a Global Pharmaceutical and Biotech manufacturer ... technology and turnkey solution to protect their animal ... http://photos.prnewswire.com/prnh/20141021/153438 Photo - ... was serialized and aggregated by the Xyntek and ...
Breaking Medicine Technology:Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors 2Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors 3BabyCenter Finds Mom Ready to Live the "Measured Life" in its U.S. Mobile Mom 2014 Report: Health & Fitness Go Mobile for Moms 2BabyCenter Finds Mom Ready to Live the "Measured Life" in its U.S. Mobile Mom 2014 Report: Health & Fitness Go Mobile for Moms 3BabyCenter Finds Mom Ready to Live the "Measured Life" in its U.S. Mobile Mom 2014 Report: Health & Fitness Go Mobile for Moms 4Xyntek and Antares Serialization Solution Protects Pets Too! 2
... 17, 2011 Clontech Laboratories, Inc., a wholly-owned ... release of the Tet-Express Inducible Expression System ... expression technology yet. At the heart of this ... Clontech,s Tet-Off® Advanced transcriptional activator protein (the Tet-Express ...
... Echo Therapeutics, Inc. (OTC Bulletin Board: ... as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) ... delivery, announced that development of the commercially ready Symphony ... that the system will be ready for demonstration in ...
Cached Medicine Technology:Announcement - Clontech Laboratories, Inc. Releases the Tet-Express™ Inducible Expression System 2Announcement - Clontech Laboratories, Inc. Releases the Tet-Express™ Inducible Expression System 3Echo Therapeutics Reports Symphony™ tCGM System Ahead of Schedule 2Echo Therapeutics Reports Symphony™ tCGM System Ahead of Schedule 3
... been selling replacement bulbs on ... we are extremely proud of ... out our catalog of replacement ... light bulbs specials. ,Check ...
... has been selling replacement bulbs ... and we are extremely proud ... Check out our catalog of ... discount light bulbs specials. ...
... Direct has been selling replacement ... 1996, and we are extremely ... guarantee. Check out our catalog ... our discount light bulbs specials. ...
... Bulb Direct has been selling ... since 1996, and we are ... satisfaction guarantee. Check out our ... see our discount light bulbs ...
Medicine Products: